M&T Bank Corp Purchases 4,684 Shares of Tenet Healthcare Corporation $THC

M&T Bank Corp raised its position in Tenet Healthcare Corporation (NYSE:THC) by 91.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,785 shares of the company’s stock after acquiring an additional 4,684 shares during the quarter. M&T Bank Corp’s holdings in Tenet Healthcare were worth $1,945,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Triumph Capital Management bought a new position in Tenet Healthcare in the third quarter valued at about $25,000. William B. Walkup & Associates Inc. bought a new position in Tenet Healthcare in the third quarter valued at about $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter valued at about $35,000. Westside Investment Management Inc. lifted its holdings in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Finally, Geneos Wealth Management Inc. increased its position in Tenet Healthcare by 50.9% in the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock worth $46,000 after buying an additional 89 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. Insiders sold 46,517 shares of company stock valued at $10,943,111 in the last ninety days. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

NYSE THC opened at $190.37 on Friday. The stock has a market capitalization of $16.40 billion, a PE ratio of 9.90, a P/E/G ratio of 1.29 and a beta of 1.30. The business has a 50 day simple moving average of $204.80 and a two-hundred day simple moving average of $204.17. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 17.56 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

THC has been the subject of a number of analyst reports. Guggenheim reduced their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a research report on Friday, May 1st. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. KeyCorp reduced their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Truist Financial upped their price target on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Nineteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.